Cécile Asher
Role not yet determined Is this you? Add your title
Also affiliated: Arkansas Children's Hospital (2025); Alder Hey Children's Hospital (1936)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Cécile Asher's research focuses on neonatal outcomes related to maternal opioid use and withdrawal. Her recent work investigates the association between medication for opioid use disorder during pregnancy and outcomes for newborns, including birth weight and intelligence. Asher has also studied accelerated weaning of opioids to reduce pharmacologic exposure for Neonatal Opioid Withdrawal Syndrome in a randomized clinical trial. Her earlier publications explored the prognosis of immaturity and the relationship between birth weight and intelligence. Asher has collaborated with Elizabeth A. Sellars, Megan S. Evans, Jennifer Good, and Richard Hall at the University of Arkansas for Medical Sciences. Her scholarship metrics include an h-index of 4, with 10 total publications and 47 citations.
Metrics
- h-index: 3
- Publications: 7
- Citations: 36
Selected Publications
-
Accelerated Weaning of Opioids to Reduce Pharmacologic Exposure for Neonatal Opioid Withdrawal Syndrome: A Randomized Clinical Trial (2026)
-
Association between medication for opioid use disorder during pregnancy and neonatal outcomes (2025)
-
Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome in monozygotic twins with a novel tumor protein p63 gene pathogenic variant (2025)
Collaboration Network
Top Collaborators
- Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome in monozygotic twins with a novel tumor protein p63 gene pathogenic variant
- Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome in monozygotic twins with a novel tumor protein p63 gene pathogenic variant
- Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome in monozygotic twins with a novel tumor protein p63 gene pathogenic variant
- Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome in monozygotic twins with a novel tumor protein p63 gene pathogenic variant
- Association between medication for opioid use disorder during pregnancy and neonatal outcomes
- Association between medication for opioid use disorder during pregnancy and neonatal outcomes
- Association between medication for opioid use disorder during pregnancy and neonatal outcomes
- Association between medication for opioid use disorder during pregnancy and neonatal outcomes
- Association between medication for opioid use disorder during pregnancy and neonatal outcomes
- Association between medication for opioid use disorder during pregnancy and neonatal outcomes
- Association between medication for opioid use disorder during pregnancy and neonatal outcomes
- Association between medication for opioid use disorder during pregnancy and neonatal outcomes
- Association between medication for opioid use disorder during pregnancy and neonatal outcomes
- Association between medication for opioid use disorder during pregnancy and neonatal outcomes
- Association between medication for opioid use disorder during pregnancy and neonatal outcomes
Similar Researchers
Based on overlapping research topics